How to Best Measure Disease Progression in Adult Spinal Muscular Atrophy Patients: A Clinical and Neurophysiological Study
da Graça FF, Iwabe C, Nucci A, de Rezende TJR, França MC Jr.
Muscle Nerve 2026 Feb 2. doi: 10.1002/mus.70169
This study aimed to identify the most sensitive clinical, patient-reported, and neurophysiological measures to detect short-term disease progression in untreated adult SMA patients. Amongst every clinician-reported outcomes (MFM, HFMSE, RULM) and patient-reported outcomes (MFIS, CMAP, MUNIX), the MFM was the most sensitive to short-term progression and most closely aligned with neurophysiological markers, supporting its use as primary outcome in clinical trials involving adult SMA patients.
Articles in scientific journal
Activity rating scales in adult muscle disease: what do they actually measure?
Seedat F, James MK, Rose MR. Muscle Nerve. 2014. 50(1):14-23. Literature review of activity rating scales used for muscle disease and assessed their content by linking scale items to the International Classification of Functioning, Disability and Health (ICF) and the...
The Use of Functional Scales for Clinical Evaluation of Duchenne Muscular Dystrophy
Barra TMF, Baraldi KF Revista Neurociências. 2013. 21(3):420-426. Literature review of scientific articles, books and dissertations published from 2000 to 2011, in Portuguese, English and Spanish languages to demonstrate the applicability of using Vignos scales, Egen...
Assisted bicycle training delays functional deterioration in boys with duchenne muscular dystrophy: the randomized controlled trial “no use is disuse”.
Jansen M, van Alfen N, Geurts AC, de Groot IJ. Neurorehabil Neural Repair. 2013. 27(9):816-27. Thirty boys (18 ambulant and 12 wheelchair-dependent) with a DMD were physically trained using an assisted bicycle. After 24 weeks, the total MFM score remained stable in...
Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients.
Servais L, Deconinck N, Moraux A, Benali M, Canal A, Van Parys F, Vereecke W, Wittevrongel S, Mayer M, Desguerre I, Maincent K, Themar-Noel C, Quijano-Roy S, Serari N, Voit T, Hogrel JY. Neuromuscul Disord. 2013. 23(2) : 139-48. Development of new tools to precisely...
Motor Function Measure: validation of a short form (MFM-20) for young children with neuromuscular diseases
Capucine de Lattre, Christine Payan, Carole Vuillerot, Pascal Rippert, Denis de Castro, Carole Bérard, Isabelle Poirot and the MFM-20 Study Group. Arch Phys Med Rehabil. 2013. 94 : 2218-26. Validation of MFM version useful in neuromuscular children under 7 years old,...
Responsiveness of the Motor Function Measure in Patients With Spinal Muscular Atrophy.
Vuillerot C, Payan C, Iwaz J, Ecochard R, Bérard C and the MFM Spinal Muscular Atrophy Study Group. Arch Phys Med Rehabil. 2013. 94(8) : 1555-61. Assessment in 112 patients with Spinal Muscular Atrophy (SMA) aged 5.7 to 59 years of the ability of the MFM to detect...